DBV Technologies



Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amarin USD -24415000 24.65M 2024-09
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
DBV Technologies USD -27409000 2.3M 2024-09
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Insmed USD -241795000 46.45M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
United Therapeutics USD 383.4M 43.9M 2024-12



DBV Technologies - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.